Prot# H6Q-MC-S018: A Randomized Phase 2 Study of Irinotecan Plus Cetuximab With or Without Enzasturin in Patients with Recurrent Colorectal Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date4/3/073/1/12

Funding

  • Ingenix Pharmaceutical Services, Inc. (H6Q-MC-S018 // H6Q-MC-S018)
  • Eli Lilly and Company (H6Q-MC-S018 // H6Q-MC-S018)